Diagnostic options · UAE

Single Gene tests in Dubai & UAE

Compare available Single Gene tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

332

Listed price range

2,000.00–2,800.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Single Gene test prices

Showing 121–135 of 332 matching tests.

Single Gene diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-6394 GCDH Gene Glutaric Acidemia Type 1 Genetic Test This test identifies pathogenic variants in the GCDH gene to confirm a diagnosis of Glutaric Acidemia Type 1 (GA1).	Whole Blood, Extracted DNA, One Drop Blood on FTA Card	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the GCDH gene", "Single nucleotide variants", "Copy number changes"] Parameters [] Preparation ["Do not discontinue any prescribed medication or dietary regimen without explicit guidance from your managing metabolic physician."] Indications ["Confirmation of GA1 diagnosis", "Carrier screening", "Family risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 86586-2 ICD-10: E72.3, Z14.8, Z15.89 Clinical summary This test identifies pathogenic variants in the GCDH gene to confirm a diagnosis of Glutaric Acidemia Type 1 (GA1).
TEST-4621 GCH1 Gene Hyperphenylalaninemia, BH4-Deficient Type B, Genetic Test This genetic test identifies pathogenic variants in the GCH1 gene, confirming a diagnosis of BH4-deficient hyperphenylalaninemia type B.	Peripheral Whole Blood, Extracted DNA, or Dried Blood Spot (FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["GCH1 gene sequence", "Pathogenic variants"] Parameters [] Preparation [] Indications ["Suspected BH4-deficient hyperphenylalaninemia type B", "Need to differentiate from classic phenylketonuria"] Measurement technique Confirm with laboratory Codes LOINC: 100363-1 ICD-10: E70.1 Clinical summary This genetic test identifies pathogenic variants in the GCH1 gene, confirming a diagnosis of BH4-deficient hyperphenylalaninemia type B.
TEST-2673 GDF6 Gene Klippel‑Feil Syndrome Type 1 Autosomal Dominant NGS Test This test evaluates the GDF6 gene for pathogenic variants associated with Klippel‑Feil Syndrome Type 1.	Peripheral Blood – EDTA Whole Blood (3–5 mL)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the GDF6 gene"] Parameters [] Preparation ["Pre-test genetic counselling is mandatory"] Indications ["Diagnosis of Klippel‑Feil Syndrome Type 1", "Carrier status clarification in relatives"] Measurement technique Confirm with laboratory Codes LOINC: 96653-6 ICD-10: Q76.1 Clinical summary This test evaluates the GDF6 gene for pathogenic variants associated with Klippel‑Feil Syndrome Type 1.
TEST-5035 GDI1 Gene X-Linked Intellectual Disability Type 41 Genetic Test This test evaluates the GDI1 gene for pathogenic variants associated with X-linked intellectual disability type 41.	Peripheral Blood or Dried Blood Spot (FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the GDI1 gene"] Parameters [] Preparation [] Indications ["Suspected X-linked intellectual disability type 41", "Family history of X-linked intellectual disability"] Measurement technique Confirm with laboratory Codes LOINC: 81247-3 ICD-10: F78.9 Clinical summary This test evaluates the GDI1 gene for pathogenic variants associated with X-linked intellectual disability type 41.
TEST-2993 GDNF Gene Congenital Central Hypoventilation Syndrome (CCHS) Genetic Test This test identifies genetic mutations in the GDNF gene associated with Congenital Central Hypoventilation Syndrome (CCHS).	Peripheral Whole Blood (EDTA)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the GDNF gene", "Single nucleotide variants (SNVs)", "Small insertions/deletions (indels)", "Copy number variations (CNVs)"] Parameters [] Preparation ["Ensure child is well-hydrated", "Comfort the child before sample collection"] Indications ["Suspected Congenital Central Hypoventilation Syndrome (CCHS)", "Family history of CCHS", "Need for genetic counseling and cascade testing"] Measurement technique Confirm with laboratory Codes LOINC: 21663-5 ICD-10: G47.35 Clinical summary This test identifies genetic mutations in the GDNF gene associated with Congenital Central Hypoventilation Syndrome (CCHS).
TEST-2999 GFRA1 Gene (Congenital Central Hypoventilation Syndrome) Genetic Test This genetic test analyzes the GFRA1 gene to detect mutations causing Congenital Central Hypoventilation Syndrome (CCHS). It identifies pathogenic variants within the full coding r...	Peripheral Whole Blood (3–5 mL in EDTA tube); alternative buccal swab accepted for neonates with prior clinical consultation	21–28 Business Days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the GFRA1 gene", "Single-nucleotide variants", "Small insertions/deletions", "Canonical splice-site alterations"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any medications"] Indications ["Neonates, children, and adults with suspected CCHS", "Diagnostic confirmation of CCHS", "Genetic counselling for families with CCHS"] Measurement technique Confirm with laboratory Codes LOINC: 101185-5 ICD-10: G47.35 Clinical summary This genetic test analyzes the GFRA1 gene to detect mutations causing Congenital Central Hypoventilation Syndrome (CCHS). It identifies pathogenic variants within the full coding region of the gene.
TEST-4613 GGCX Gene Analysis: Pseudoxanthoma Elasticum-like Disorder with Multiple Coagulation Factor Deficiency (NGS) Test This diagnostic test uses Next-Generation Sequencing (NGS) to identify pathogenic variants within the GGCX gene.	Whole Blood (EDTA) or Dried Blood Spot on FTA Card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the GGCX gene", "Single nucleotide variants", "Copy number changes"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist of any bleeding disorders or anticoagulant use"] Indications ["Diagnosis of pseudoxanthoma elasticum-like disorder", "Diagnosis of multiple coagulation factor deficiency", "Family screening for GGCX variants"] Measurement technique Confirm with laboratory Codes LOINC: 55233-1 ICD-10: Q82.8, D68.8 Clinical summary This diagnostic test uses Next-Generation Sequencing (NGS) to identify pathogenic variants within the GGCX gene.
TEST-3540 GJA8 Gene Cataract‑Microcornea Syndrome Genetic Test This test evaluates the GJA8 gene for pathogenic variants associated with cataract-microcornea syndrome.	Whole Blood (EDTA), Buccal Swab, or FTA Card	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["GJA8 gene coding region", "GJA8 gene splice sites"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any medications"] Indications ["Diagnosis of suspected cataract-microcornea syndrome", "Pre-surgical planning for congenital cataracts", "Genetic counseling for families with affected individuals"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: Q12.0 Clinical summary This test evaluates the GJA8 gene for pathogenic variants associated with cataract-microcornea syndrome.
TEST-4675 GJC2 Gene Hypomyelinating Leukodystrophy (Genetic Test) This genetic test identifies pathogenic variants in the GJC2 gene, confirming a diagnosis of hypomyelinating leukodystrophy (Pelizaeus‑Merzbacher‑like disease type 1).	Peripheral Whole Blood (EDTA) or Dried Blood Spot (FTA Card)	21–28 days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the GJC2 gene", "Coding region coverage of the GJC2 gene"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any medications being taken"] Indications ["Suspected hypomyelinating leukodystrophy (Pelizaeus‑Merzbacher‑like disease type 1)", "Family history of leukodystrophy", "Need for precise molecular diagnosis for clinical management", "Genetic counseling for affected families"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: G37.8 Clinical summary This genetic test identifies pathogenic variants in the GJC2 gene, confirming a diagnosis of hypomyelinating leukodystrophy (Pelizaeus‑Merzbacher‑like disease type 1).
TEST-3088 GMPPA Gene Alacrima, Achalasia, and Mental Retardation Syndrome Genetic Test This test evaluates the GMPPA gene for pathogenic variants associated with Alacrima, Achalasia, and Mental Retardation (AAMR) syndrome.	Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot (FTA Card)	3 to 4 Weeks (guaranteed from sample receipt)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["GMPPA gene sequence", "Pathogenic variants (missense, nonsense, small indels, copy-number changes)"] Parameters [] Preparation ["Genetic counselling session and signed informed consent from legal guardian (mandatory)"] Indications ["Children presenting with unexplained alacrima, achalasia, and developmental delay", "Families with a known history of AAMR syndrome", "Carrier screening in consanguineous couples"] Measurement technique Confirm with laboratory Codes LOINC: 82498-5 ICD-10: Q87.8 Clinical summary This test evaluates the GMPPA gene for pathogenic variants associated with Alacrima, Achalasia, and Mental Retardation (AAMR) syndrome.
TEST-6128 GNA11 Gene Hypocalcemia, Autosomal Dominant 2 (Genetic Test) This test identifies pathogenic variants in the GNA11 gene associated with autosomal dominant hypocalcemia type 2.	Whole blood (EDTA), extracted DNA, or FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the GNA11 gene", "Calcium metabolism regulation"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue medications without consulting your physician"] Indications ["Suspected autosomal dominant hypocalcemia type 2", "Family history of hypocalcemia", "Unexplained hypocalcemia"] Measurement technique Confirm with laboratory Codes LOINC: 91711-5 ICD-10: E83.51 Clinical summary This test identifies pathogenic variants in the GNA11 gene associated with autosomal dominant hypocalcemia type 2.
TEST-4207 GNAQ Gene Sequencing Test for Developmental Delay This test evaluates the GNAQ gene for mutations associated with developmental delay and neurodevelopmental disorders using Next-Generation Sequencing (NGS) with Sanger confirmation...	Peripheral whole blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["GNAQ gene coding region", "Point mutations", "Small insertions/deletions", "Copy number variations"] Parameters [] Preparation [] Indications ["Suspected GNAQ-related disorder", "Developmental delay of unknown etiology"] Measurement technique Confirm with laboratory Codes LOINC: 95279-9 ICD-10: R62.50 Clinical summary This test evaluates the GNAQ gene for mutations associated with developmental delay and neurodevelopmental disorders using Next-Generation Sequencing (NGS) with Sanger confirmation.
TEST-3784 GPD1 Gene Sequencing for Transient Infantile Hypertriglyceridemia Test This test identifies pathogenic variants in the GPD1 gene associated with Transient Infantile Hypertriglyceridemia (HTGTI).	Peripheral whole blood (3–5 mL EDTA) or buccal swab	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["GPD1 gene sequence", "Pathogenic variants in GPD1"] Parameters [] Preparation ["No specific patient preparation required"] Indications ["Neonates and infants with unexplained elevated triglycerides", "Differential diagnosis of hypertriglyceridemia"] Measurement technique Confirm with laboratory Codes LOINC: 55233-1 ICD-10: E78.1, E78.3 Clinical summary This test identifies pathogenic variants in the GPD1 gene associated with Transient Infantile Hypertriglyceridemia (HTGTI).
TEST-4880 GPT2 Gene Genetic Test This test detects pathogenic variants in the GPT2 gene associated with Mental Retardation, Autosomal Recessive Type 49 (MRT49).	Peripheral Blood	3–4 Weeks (Standard)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in GPT2 gene", "SNVs", "Indels", "Copy number changes (MLPA)"] Parameters [{"name": "Variant Detection", "reference_range": "SNVs, indels, copy number changes (MLPA)"}, {"name": "Method", "reference_range": "NGS – Illumina platform with >500x depth"}, {"name": "Analytic Sensitivity", "reference_range": ">99.9% for single-nucleotide variants and small indels"}] Preparation ["No specific fasting required", "Do not discontinue prescribed medications without consulting a physician"] Indications ["Suspected MRT49 based on clinical findings", "Family history of MRT49", "Carrier testing for family members"] Measurement technique Confirm with laboratory Codes LOINC: 101120-6 ICD-10: F79, Z13.71, Z14.8 Clinical summary This test detects pathogenic variants in the GPT2 gene associated with Mental Retardation, Autosomal Recessive Type 49 (MRT49).
TEST-3765 GSN Gene Finnish Type Amyloidosis Genetic Test This genetic test detects mutations in the GSN gene associated with hereditary gelsolin amyloidosis (Meretoja disease). It helps identify individuals at risk or confirm the diagnos...	Whole blood (EDTA tube), extracted DNA, or dried blood spot on FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Mutations in the GSN gene", "Single nucleotide variants", "Small insertions and deletions", "Splice-site alterations"] Parameters [{"name": "Analytical Sensitivity", "reference_range": ">99.9% for single nucleotide variants and small indels"}, {"name": "Methodology", "reference_range": "NGS – full gene coverage with high-depth sequencing"}] Preparation ["Pre-test genetic counselling session with pedigree charting is mandatory before sample collection."] Indications ["Symptomatic patients with suspected hereditary gelsolin amyloidosis", "Predictive testing for at-risk family members"] Measurement technique Confirm with laboratory Codes LOINC: 94219-7 ICD-10: E85.2 Clinical summary This genetic test detects mutations in the GSN gene associated with hereditary gelsolin amyloidosis (Meretoja disease). It helps identify individuals at risk or confirm the diagnosis in symptomatic patients.

Category overview

Single Gene: overview

When clinical symptoms or family history point directly toward a specific inherited condition, highly focused genetic testing provides the exact, rapid insights necessary for peace of mind. Integrated into our advanced Molecular Genetics services, Single Gene testing meticulously analyzes one specific gene for known disease-causing mutations. Utilizing cutting-edge diagnostic technology, this highly focused molecular screening helps confirm or rule out precise genetic traits, safely guiding targeted medical interventions and family planning strategies. Recognized for specialized diagnostic excellence among diagnostic labs in the UAE, DNA Labs ensures absolute patient confidentiality, exceptional analytical precision, and incredibly efficient turnaround times. Take an informed step forward in your health journey—schedule your single gene testing in UAE, book a secure home sample collection, or reach out to our expert medical professionals.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.